SPOTLIGHT -
Leniolisib approved as first treatment for PI3K-delta syndrome in patients 12 years and older
Leniolisib is the first and only treatment approved in the United States for APDS, a rare primary immunodeficiency.
Food Insecurity and the Dangers of Infant Formula Dilution
RSV surged in 2022 but appears to make early retreat in 2023
New maternal vaccine options could offer extra protection in upcoming seasons.
Demystifying Infant Formula
FDA approves dabrafenib plus trametinib and liquid formulations to treat BRAF V600E low-grade glioma
Pediatric patients with BRAF V600E low-grade glioma as young as 1 year can now be treated with dabrafenib plus trametinib following its FDA approval.
Poll reveals how parents determine risks, punishments, and likelihood of vaping in their children
A recent survey from the C.S. Mott Children’s Hospital National Poll on Children’s Health revealed how addictive parents believe vaping is for children.
